MedPath

A study for the difference in effects of high-dose prednisolone therapy for autoimmune disease patients

Not Applicable
Recruiting
Conditions
rheumatic disease like dermatomyositis, polymyositis, systemic lupus erythematosus, vasculitides, adult Still&#39
s disease and so on.
Registration Number
JPRN-UMIN000007673
Lead Sponsor
Graduate School of Medicine Kyoto University Rheumatology and Clinical Immunology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have taken oral prednisolone for long time Patients who have allergy to prednisolone

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of the Disease activity of rheumatic diseases 2 weeks after the induction of oral prednisolone therapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath